pharma news today obesity drug glp-1 Pipeline Update: August 2025 - Prime Therapeutics GLP-1 Antagonists Increase Plan Drug

Diabetes and obesity both predispose patients to cardiovascular diseases, neurodegenerative diseases, and many other diseases of aging

Stroke benefit and best timing remain uncertain

These improvements are generally attributed to enhanced glycemic control and reduced inflammatory signaling rather than to expansion of substrate-dependent antioxidant buffering capacity

Benefits: Brightens skin Evens out skin tone Improves overall skin health Contains: Ascorbic Acid (Vitamin C): A powerhouse antioxidant that supports collagen production and skin elasticity

Laboratory biomarkers Blood testing provides clinical-grade assessment of metabolic status